Vimarsana
Biggest News Aggregation in the World

Page 6 - Peter Kaiser News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peter Kaiser. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peter Kaiser Today - Breaking & Trending Today

REGENXBIO to Host Virtual Investor Day Highlighting AAV Pipeline Programs with Upcoming Interim Trial Updates - Vimarsana News

REGENXBIO to Host Virtual Investor Day Highlighting AAV Pipeline Programs with Upcoming Interim Trial Updates

/PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will host a virtual investor day on July 11, 2023. During the event, members of...

First passenger train through Austria's Koralm tunnel - International Railway Journal - Vimarsana News

First passenger train through Austria's Koralm tunnel - International Railway Journal

The first passenger train has operated through the 33km Koralm tunnel in Austria, part of the new line under construction between Graz and Klagenfurt.

Clearside Biomedical Enhances Scientific Advisory Board with the Appointment of Two Distinguished Retinal Physicians - Vimarsana News

Clearside Biomedical Enhances Scientific Advisory Board with the Appointment of Two Distinguished Retinal Physicians

05.04.2023 - ALPHARETTA, Ga., April 05, 2023 (GLOBE NEWSWIRE) - Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS), today announced the ... Seite 1

NW. Wisconsin musher Ryan Redington wins first Iditarod - Vimarsana News

NW. Wisconsin musher Ryan Redington wins first Iditarod

It's a lifelong dream for Redington, whose grandfather founded the 1,000-mile race.

Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q4 2022 Earnings Call Transcript - Vimarsana News

Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q4 2022 Earnings Call Transcript

Operator: Good afternoon, ladies and gentlemen. Thank you for standing by and welcome to the Ocular Therapeutix Fourth Quarter and Year-End 2022 Earnings Conference Call.